Fineotex adds two US step-down subsidiaries at full ownership

Fineotex Chemical Limited added two wholly owned US step-down subsidiaries in the quarter ended September 30, 2026, incorporating Fineotex Holdings Inc. on August 7 and Fineotex America Inc. on August 24 through Fineotex Biotex Healthguard FZE, with the filing reporting a 100% holding in each entity.

What US subsidiaries did Fineotex add?

Fineotex added Fineotex Holdings Inc. and Fineotex America Inc. as new US step-down subsidiaries during the quarter ended September 30, 2026. The disclosure in note 8 to the consolidated results says both entities were incorporated by Fineotex Biotex Healthguard FZE, which Fineotex identifies as its wholly owned subsidiary.

The structure disclosed means that the two companies sit below Fineotex Biotex Healthguard FZE rather than being stated as direct subsidiaries of Fineotex. Each new company carries a reported 100% group holding, and the filing does not identify any outside shareholder in either entity as of September 30, 2026.

The board approved the consolidated results containing this disclosure on November 13, 2026. Fineotex reported the event alongside results prepared under Indian Accounting Standard 34, or Ind AS 34, which covers interim financial reporting, but did not disclose a separate purchase price, share capital amount or asset transfer for either incorporation.

When were Fineotex Holdings and Fineotex America incorporated?

Fineotex Holdings Inc. was incorporated on August 7, 2026, and Fineotex America Inc. was incorporated on August 24, 2026. Both dates fall within the quarter under review, which ended on September 30, 2026, and both entities were reported at 100% holding.

The disclosure provides the two names, incorporation dates and ownership percentages, but does not state whether Fineotex Holdings Inc. will own Fineotex America Inc. or whether either company will hold assets, contracts or investments. The word “Holdings” in one company’s name therefore does not establish a group function beyond the incorporation reported on August 7, 2026.

Fineotex also does not disclose business activities, directors, employees, capitalisation, expected turnover or a commercial objective for the two new entities. The reported 100% holding establishes full group ownership, but the September 30, 2026 filing does not quantify revenue, expenses, assets or cash flow attributable to either company.

How did Fineotex perform in the September 2026 quarter?

Fineotex reported consolidated revenue from operations of Rs 387.653 crore for the quarter ended September 30, 2026, compared with Rs 376.6277 crore in the quarter ended June 30, 2026 and Rs 137.7054 crore in the quarter ended September 30, 2025. Revenue was therefore higher sequentially and against the prior-year quarter, although the incorporation note does not link that change to the two US entities.

Consolidated profit after tax was Rs 44.5457 crore in the September 2026 quarter, down from Rs 48.2053 crore in the preceding quarter but above Rs 26.0764 crore a year earlier. Profit attributable to Fineotex owners was Rs 34.2442 crore, while non-controlling interest accounted for Rs 10.3013 crore in the September 2026 quarter.

For the half year ended September 30, 2026, Fineotex reported revenue from operations of Rs 764.2807 crore and profit after tax of Rs 92.7509 crore, compared with Rs 274.7774 crore and Rs 51.1048 crore, respectively, for the half year ended September 30, 2025. Fineotex says it mainly operates in one primary business segment, speciality chemicals, and therefore does not provide operating-segment disclosures under Ind AS 108.

What changed in Fineotex's balance sheet by September 2026?

Fineotex reported total consolidated assets of Rs 1,244.3485 crore at September 30, 2026, compared with Rs 1,159.2167 crore at March 31, 2026. Total equity increased to Rs 978.1909 crore from Rs 882.4314 crore over the same period, while minority interest rose to Rs 70.2682 crore from Rs 57.2981 crore.

Cash and cash equivalents stood at Rs 87.9858 crore at September 30, 2026, compared with Rs 37.2646 crore at March 31, 2026. Inventories increased to Rs 203.4107 crore from Rs 154.6078 crore, while trade receivables rose to Rs 319.3092 crore from Rs 290.2861 crore; Fineotex does not attribute any of these movements to the August 2026 incorporations.

Non-current investments declined to Rs 259.8464 crore at September 30, 2026 from Rs 290.4341 crore at March 31, 2026, while current investments fell to Rs 2.0108 crore from Rs 27.0497 crore. The balance sheet lists these aggregated financial positions but contains no separate line item for Fineotex Holdings Inc. or Fineotex America Inc.

What other unresolved matter did Fineotex disclose?

Fineotex said that a legal dispute concerning an assignment agreement for property classified as assets held for sale remained unsettled as of September 30, 2026. The company had paid Rs 6.25 crore towards settlement and had received total advances of Rs 10.08 crore for the proposed transfer or assignment.

Fineotex did not recognise the sale because the property transfer had not been completed by September 30, 2026. The balance sheet carried the asset classified as held for sale at Rs 7.2069 crore at September 30, 2026, compared with Rs 7.20 crore at March 31, 2026.

The statutory auditors issued an unqualified conclusion on Fineotex’s unaudited consolidated results on November 13, 2026. Their report also says that some overseas subsidiary and step-down subsidiary financial information was management-prepared and unreviewed by those entities’ respective auditors, while another overseas subsidiary’s information was reviewed by another auditor.

Conclusion

Fineotex’s September 2026-quarter filing documents a defined expansion of its overseas legal structure, with Fineotex Holdings Inc. and Fineotex America Inc. incorporated in August 2026 through Fineotex Biotex Healthguard FZE at 100% ownership. The disclosure sits alongside consolidated quarterly revenue of Rs 387.653 crore and profit after tax of Rs 44.5457 crore, but does not assign a financial contribution or operating role to either new entity.

The next point to watch is whether Fineotex discloses the intended activities, funding or financial contribution of the two US step-down subsidiaries in later results. The unresolved property assignment dispute also remains relevant because the transfer was incomplete at September 30, 2026, despite Rs 6.25 crore paid towards settlement and Rs 10.08 crore in advances received.